Having had setbacks with torcetrapib and Exubera, and with generic competition to Norvasc and Lipitor, Pfizer is putting more emphasis into animal drugs.
Related Stories
More in Uncategorized
Comments
- Anonymous
Previous post: Clogging the ER
Next post: Talking about statins
